ESR1 and breast cancer: In the study of Hutchinson et al., it was demonstrated that MDA-MB-468 breast cancer cells (ER−) expressed significantly fewer NCOR1, NCOR2 and LCOR transcripts than the breast cancer cell line MCF7 (ER+).